TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

Treatment Efficacy and Molecular Dynamics of Neoadjuvant Durvalumab and Olaparib in Resectable Urothelial Bladder Cancer: The NEODURVARIB Trial.

Juan F Rodríguez-Moreno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.